Your Comments On...

FDA Says It Approved The Wrong Drug Plant

The Chinese facility that supplies the active ingredient of the widely used blood thinner heparin was never inspected by the Food and Drug Administration because the agency confused its name with another just like it, agency officials said yesterday.

By Marc Kaufman

© 2008 The Washington Post Company